Aid, Malika
Stephenson, Kathryn E. http://orcid.org/0000-0002-3440-4105
Collier, Ai-ris Y. http://orcid.org/0000-0002-8539-3960
Nkolola, Joseph P.
Michael, James V. http://orcid.org/0000-0001-8796-5259
McKenzie, Steven E.
Barouch, Dan H. http://orcid.org/0000-0001-5127-4659
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA260476)
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority (HHSO100201700018C)
Ragon Institute of MGH, MIT and Harvard
Janssen Research and Development
Article History
Received: 16 May 2023
Accepted: 16 October 2023
First Online: 23 October 2023
Competing interests
: D.H.B. is a co-inventor on provisional vaccine patents licensed to Janssen (63/121,482; 63/133,969; 63/135,182). S.McK. is on the Scientific Advisory Board of Veralox Therapeutics. The remaining authors declare no competing interests.